Cancer and Covid-19: A preliminary study on the trauma aspects of coronavirus in cancer patients.
COVID-19
Coping style
cancer
depression
oncological patients
oncology
post traumatic stress disorder
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
24
03
2022
received:
29
11
2021
accepted:
27
03
2022
pubmed:
9
4
2022
medline:
10
8
2022
entrez:
8
4
2022
Statut:
ppublish
Résumé
Because of Covid 19, it has become necessary to revise the treatment of cancer patients ("how" and "when"). That has had important psychological repercussions. The purpose of this study is the evaluation of the impact of Covid19 in terms of Post-Traumatic Stress Disorder and Depression and the potential association with coping strategies. We conducted an exploratory study with 106 patients undergoing treatment, using following questionnaires: Screening Questionnaire for Disaster Mental Health and Mini-Mental Adjustment to Cancer. Only 25.5% of our sample showed symptoms of posttraumatic stress disorder (PTSD) and 6.6% revealed a probable presence of depression. In addition, it came up a significant correlation between SQD_P and the coping styles "Hopelessness" (r = 0.41 p < 0.001) and "Anxious Preoccupation" (r = 0.45, p < 0.001). A strong correlation also emerged between non-Covid 19 patients and PTSD (r = 0.29, p = 0.002). Our preliminary data did not reveal a prevalence of PTSD, but the persistence of the health emergency requires to focus future research on protective and risk factors related to PTSD and psychological distress in cancer patients, in order to reduce the mental health burden of Covid19.
Identifiants
pubmed: 35394096
doi: 10.1002/pon.5936
pmc: PMC9088541
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1340-1346Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Qual Life Res. 2021 Jul;30(7):1903-1912
pubmed: 33635508
Psychooncology. 2014 Jan;23(1):40-51
pubmed: 23983079
Lancet. 2020 Jun 20;395(10241):1919-1926
pubmed: 32473682
Clin Breast Cancer. 2020 Oct;20(5):e651-e662
pubmed: 32709505
Psychooncology. 2006 Feb;15(2):132-42
pubmed: 15880387
J Pers Soc Psychol. 1988 Mar;54(3):466-75
pubmed: 3361419
Clin Transl Oncol. 2018 Nov;20(11):1392-1399
pubmed: 29611043
Asia Pac J Clin Oncol. 2018 Apr;14(2):e181-e192
pubmed: 28371441
ESMO Open. 2020 Oct;5(5):e000970
pubmed: 33097653
Neurosci Biobehav Rev. 2020 May;112:519-541
pubmed: 32092313
Lancet Public Health. 2020 Jun;5(6):e310
pubmed: 32339478
Support Care Cancer. 2018 Feb;26(2):405-414
pubmed: 29058128
Front Psychiatry. 2013 Oct 02;4:122
pubmed: 24106482
Cancer. 2018 Jan 15;124(2):406-416
pubmed: 29152719
Eur J Cancer. 2010 Jul;46(11):2036-44
pubmed: 20447824
Cancer Nurs. 2011 Jul-Aug;34(4):302-14
pubmed: 21116179
Psychooncology. 2005 Feb;14(2):115-24
pubmed: 15386782
Psychooncology. 2020 Sep;29(9):1395-1398
pubmed: 32596867
Support Care Cancer. 2020 Jan;28(1):211-220
pubmed: 31001695
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Lancet Psychiatry. 2017 Apr;4(4):330-338
pubmed: 28109647
Transl Psychiatry. 2020 Jul 31;10(1):263
pubmed: 32737292
Psychiatry Clin Neurosci. 1999 Oct;53(5):569-73
pubmed: 10595681
Psychooncology. 2006 Feb;15(2):143-59
pubmed: 15880638
J Pain Symptom Manage. 2020 Nov;60(5):e25-e34
pubmed: 32889039
BMJ. 2018 Apr 25;361:k1415
pubmed: 29695476
J Anxiety Disord. 2020 Mar;70:102196
pubmed: 32078967
Can Fam Physician. 2020 Mar;66(3):176-182
pubmed: 32165464
Psychooncology. 2022 Aug;31(8):1340-1346
pubmed: 35394096
J Clin Oncol. 2002 Jul 1;20(13):2920-9
pubmed: 12089220
Curr Treat Options Oncol. 2020 Feb 5;21(2):17
pubmed: 32025928
Updates Surg. 2020 Jun;72(2):309-310
pubmed: 32328880
Breast. 2016 Jun;27:136-68
pubmed: 27113230